Blood test could help paramedics spot severe strokes before the hospital

NCT ID NCT04726839

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether a panel of blood biomarkers can quickly identify stroke patients who have a large vessel occlusion (a major blockage) and would benefit from a specialized clot-removal procedure. Researchers enrolled nearly 3,900 adults with stroke symptoms and tested their blood in the ambulance or emergency room. The goal is to help paramedics decide which hospital to take a patient to, avoiding delays that can worsen outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
blood biomarker panel
What this could lead to
If successful, this blood test could help paramedics quickly identify stroke patients who need a specialized clot-removal procedure, getting them to the right hospital faster and improving outcomes.
What could go wrong
This is a completed study analyzing blood samples, not a treatment trial. The biomarker panel may not be accurate enough in real-world ambulance settings, and further validation is needed before it can be used routinely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LARGE VESSEL OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department Neurology Caen Hospital

    Caen, France

  • Hospital Foch

    Suresnes, France

  • Lariboisière

    Paris, 75010, France

  • Rothschild Foundation Hospital

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.